Nanoparticle-based targeted drug delivery

被引:1934
作者
Singh, Rajesh [1 ]
Lillard, James W., Jr. [1 ,2 ]
机构
[1] Univ Louisville, James Graham Brown Canc Ctr, Dept Microbiol & Immunol, Sch Med, Louisville, KY 40202 USA
[2] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA
关键词
Nanoparticles; Drug delivery; Cancer therapy; Quantum dots; XPclad (c) nanoparticles; BIODEGRADABLE NANOPARTICLES; PARTICLE-SIZE; RELEASE; TUMOR; DEGRADATION; COPOLYMER; ENCAPSULATION; MICROSPHERES; TECHNOLOGY; CHITOSAN;
D O I
10.1016/j.yexmp.2008.12.004
中图分类号
R36 [病理学];
学科分类号
100103 [病原生物学];
摘要
Nanotechnology could be defined as the technology that has allowed for the control, manipulation, study. and manufacture of structures and devices in the "nanometer" size range. These nano-sized objects, e.g., "nanoparticles", take on novel properties and functions that differ markedly from those seen from items made of identical materials. The small size, customized surface, improved solubility, and multi-functionality of narroparticles will continue to open many doors and create new biomedical applications. Indeed, the novel properties of nanoparticles offer the ability to interact with complex cellular functions in new ways. This rapidly growing field requires cross-disciplinary research and provides opportunities to design and develop multifunctional devices that can target, diagnose, and treat devastating diseases such as cancer. This article presents an overview of nanotechnology for the biologist and discusses the attributes of our novel XPclad(C) nanoparticle formulation that has shown efficacy in treating solid tumors, single dose vaccination, and oral delivery of therapeutic proteins. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 60 条
[1]
Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation [J].
Ahmed, Fariyal ;
Pakunlu, Refika I. ;
Srinivas, Goundla ;
Brannan, Aaron ;
Bates, Frank ;
Klein, Michael L. ;
Minko, Tamara ;
Discher, Dennis E. .
MOLECULAR PHARMACEUTICS, 2006, 3 (03) :340-350
[2]
Fullerene (C60) immunoconjugates:: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody [J].
Ashcroft, Jared M. ;
Tsyboulski, Dmitri A. ;
Hartman, Keith B. ;
Zakharian, Tatiana Y. ;
Marks, John W. ;
Weisman, R. Bruce ;
Rosenblum, Michael G. ;
Wilson, Lon J. .
CHEMICAL COMMUNICATIONS, 2006, (28) :3004-3006
[3]
PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in Vivo drug residence in blood properties [J].
Avgoustakis, K ;
Beletsi, A ;
Panagi, Z ;
Klepetsanis, P ;
Karydas, AG ;
Ithakissios, DS .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :123-135
[4]
Barratt, 2000, Pharm Sci Technol Today, V3, P163
[5]
SYNTHESIS AND RGD PEPTIDE MODIFICATION OF A NEW BIODEGRADABLE COPOLYMER - POLY(LACTIC ACID-CO-LYSINE) [J].
BARRERA, DA ;
ZYLSTRA, E ;
LANSBURY, PT ;
LANGER, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (23) :11010-11011
[6]
Effect of preparative variables on the properties of poly(dl-lactide-co-glycolide) methoxypoly(ethyleneglycol) copolymers related to their application in controlled drug delivery [J].
Beletsi, A ;
Leontiadis, L ;
Klepetsanis, P ;
Ithakissios, DS ;
Avgoustakis, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (02) :187-197
[7]
Bhadra D, 2002, PHARMAZIE, V57, P5
[8]
Polymeric nanoparticle-encapsulated curcumin (nanocurcumin"): A novel strategy for human cancer therapy" [J].
Bisht S. ;
Feldmann G. ;
Soni S. ;
Ravi R. ;
Karikar C. ;
Maitra A. ;
Maitra A. .
Journal of Nanobiotechnology, 5 (1)
[9]
Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[10]
Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines [J].
Calvo, P ;
RemunanLopez, C ;
VilaJato, JL ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1997, 14 (10) :1431-1436